FindTrial
Sign In

Participants having Nidranash divided into two groups where one group get Til Taila Shirodhara and other get Til Taila Shirodhara with Jatamansi Tail Nasya as treatment for 7 days.

A comparative clinical study of shirodhara with and without jatamansi tail nasya in nidranasha with special reference to primary insomnia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/073069
Enrollment
40
Registered
2024-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F489- Nonpsychotic mental disorder, unspecified

Interventions

None listed

Sponsors

SANE GURUJI AROGYA KENDRA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients showing maximum classical sign and symptoms of Nidranasha. Gender- Both male and female patients included. Age group: 30-60 year is included. Sign and symptoms of Stressful life situation causing insomnia (Primary Insomnia). Nasya Arha. Shirodhara Arha. Patient having Sleep Efficiency Index (SEI) below 80%

Exclusion criteria

Exclusion criteria: Known case of systemic diseases which interfere the treatment. Chronic alcoholism, drug dependent, chronic mental disorders and mental diseases.

Design outcomes

Primary

MeasureTime frame
To assess the add-on effect of Jatamansi Tail Nasya along with Shirodhara by Til Tail in Nidranasha with special reference to primary insomnia.Timepoint: TREATMENT WILL BE GIVEN FOR 7 DAYS.PATIENTS WILL BE ASSESSED ON 0TH,7TH AND FOLLOW UP ON 15TH DAY.—

Secondary

MeasureTime frame
To study the effect of Til Tail Shirodhara in Nidranasha with special reference to primary insomnia.Timepoint: PATIENTS WILL BE ASSESSED ON 0TH,7TH AND FOLLOW UP ON 15TH DAY.—

Countries

India

Contacts

Public ContactDr Srujali Gat

Sumatibhai Shah Ayurved Mahavidyalay Malwadi Hadapsar Pune

drmayagokhale@gmail.com9422323285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026